Management Changes at Bruker
Among Bruker’s most immediate financial goals on which Mr. Knight will be focused for Bruker Scientific Instruments are a 100-200 basis point improvement in operating margin. In 2012, the company aims for operating margins greater than or equal to 15%.
Billerica, MA 11/9/09; Washington, DC 11/13/09—Bruker has announced two changes at the executive level. The company has appointed CFO Bill Knight to the newly created position of chief operating officer, effective February 1, 2010. “Over the past five years, Bill Knight has demonstrated strong financial and operational leadership at Bruker, and in his newly-created COO role Bill will lead and fully focus on our operation excellence initiative,” stated Bruker President and CEO Frank Laukien. Chief Accounting Officer Brian Monahan will replace Mr. Knight as CFO. In a regulatory filing, Bruker announced that as of November 11, Dirk D. Laukien, PhD, has resigned from his positions as senior vice president of Bruker and president of Bruker Optics. Effective February 1, 2010, he will resign as co-CEO of Bruker BioSpin. The filing stated that he resigned to devote more time to personal interests. Dr. Laukien will remain with Bruker as a senior scientific fellow and continue to serve on the Board.
